Epidemiological association between C-reactive protein and prostate specific antigen

Cancer

Volumn 115, Issue 5, 2009, Pages 1132-

  Lippi, Giuseppe ^a   Montagnana, Martina ^a   Guidi, Gian Cesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; CANCER SCREENING; CANCER SUSCEPTIBILITY; CHI SQUARE TEST; CORRELATION ANALYSIS; HUMAN; LETTER; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RANK SUM TEST; RETROSPECTIVE STUDY;

ADULT; C-REACTIVE PROTEIN; HUMANS; MALE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 61449266634     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24116     Document Type: Letter

References (2)

1. Beer TM, Lalani AS, Lee S, et al. C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial. Cancer. 2008;112:2377-2383.
2. Gilbert SM, Cavallo CB, Kahane H, et al. Evidence suggesting PSA cutpoint of 2.5 ng/mL for prompting prostate biopsy: review of 36,316 biopsies. Urology. 2005;65:549-553.